BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beigneux Y, Arnulf I, Guillaume-Jugnot P, Leu-Semenescu S, Maillart E, Lubetzki C, Benveniste O, Papeix C. Secondary hypersomnia as an initial manifestation of neuromyelitis optica spectrum disorders. Mult Scler Relat Disord 2020;38:101869. [PMID: 31785490 DOI: 10.1016/j.msard.2019.101869] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Pique J, Nicolas P, Marignier R. Neuromielite ottica acuta (malattia di Devic). EMC - Neurologia 2022;22:1-11. [DOI: 10.1016/s1634-7072(22)47095-4] [Reference Citation Analysis]
2 Sleep and Autoimmunity. Autoimmune Encephalitis and Related Disorders of the Nervous System 2022. [DOI: 10.1017/9781108696722.023] [Reference Citation Analysis]
3 Moura J, Pinto E, Coutinho E, Carneiro P, Neves E, Correia C, Santos E. Recurrent diencephalic involvement as the sole manifestation of anti-aquaporin 4 antibody-positive disorder in an adult patient. Neuroimmunology Reports 2022;2:100114. [DOI: 10.1016/j.nerep.2022.100114] [Reference Citation Analysis]
4 Etemadifar M, Nouri H, Khorvash R, Salari M, Ghafari K, Aghababaee A. Frequency of diencephalic syndrome in NMOSD. Acta Neurol Belg 2021. [PMID: 34515964 DOI: 10.1007/s13760-021-01792-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Abboud H, Salazar-Camelo A, George N, Planchon SM, Matiello M, Mealy MA, Goodman A; On-behalf of the Guthy-Jackson Foundation NMO International Clinical Consortium. Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders. J Neurol 2021. [PMID: 34482456 DOI: 10.1007/s00415-021-10783-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gul M, Jafari AA, Shah M, Mirmoeeni S, Haider SU, Moinuddin S, Chaudhry A. Molecular Biomarkers in Multiple Sclerosis and Its Related Disorders: A Critical Review. Int J Mol Sci 2020;21:E6020. [PMID: 32825639 DOI: 10.3390/ijms21176020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
7 Duchow A, Paul F, Bellmann-strobl J. Current and emerging biologics for the treatment of neuromyelitis optica spectrum disorders. Expert Opinion on Biological Therapy 2020;20:1061-72. [DOI: 10.1080/14712598.2020.1749259] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]